That said, regular monitoring and dose adjustments are essential
And variability in absorption remains a significant challenge for all nasal peptide products
This would be dramatically more effective than the one-size-fits-all approach that current products, including Pendulum, use
Leveraging these technological and strategic advancements allows researchers to bring innovative transdermal patches to patients faster and more reliably
Integration of GLP-1RA or SGLT2i in Patients With T2D With or at Risk of atherosclerotic CVD PICO 4: In patients with T2D and either atherosclerotic CVD (ASCVD) or high CV risk, what is the role of novel anti-hyperglycemic agents compared with placebo for reduction of a composite of CV death, nonfatal MI, or nonfatal stroke
Peer review Peer review information Nature Metabolism thanks Nigel Irwin, Michael Nauck and Brian Finan for their contribution to the peer review of this work